FSIS
NOTICE |
44-01
|
10-11-01
|
This Notice Has Expired; It is
Provided Here for Information Purposes Only.
CLARIFICATION OF CATTLE RESIDUE
TESTING PROCEDURES
Why is FSIS issuing this Notice?
FSIS is issuing this Notice to ensure that Veterinarian
Medical Officers (VMO) continue to have clarification of
FSIS’s policies regarding when to use rapid in-plant tests
(i.e., Swab Test on Premises (STOP) or Fast Antimicrobial
Screening Test (FAST)). The information in this Notice is
the same as that found in FSIS Notice 24-00.
USE OF RAPID IN-PLANT TESTS
When do
VMOs conduct rapid in-plant residue tests?
FSIS has trained all VMOs to conduct rapid in-plant tests on
carcasses with the types of pathologies or conditions listed
below and to retain the tested carcasses until the test
results are received. Carcasses with such pathologies or
conditions are at risk for residue violations. However,
there are no instructions that effect this training. This
Notice serves that purpose.
The following is a list
of the pathologies and conditions that warrant retention and
testing of carcasses. Symptoms are described to help VMOs
determine when to retain and test carcasses.
- Mastitis – carcasses with inflammatory
ventral edema in the perineal area resulting from mastitis.
Hemorrhages and yellow serous infiltrate, located ventrally, are
typically present.
- Metritis – carcasses with acute metritis. Associated
pathology includes enlargement of the uterine body,
distension of the uterine horns with a fetid brown, red
brown, or black fluid; thinning of the uterine wall; and
lack of evidence of normal uterine involution (no lines
of contracture in the myometrium).
- Peritonitis and surgery – carcasses with active
peritoneal inflammation associated with fibrinous
exudate or fetid ascitic fluid, no matter how limited
the extent of the lesions or with ventral abdominal
cellulitis secondary to percutaneous abomasal surgery.
Findings of surgical devices (suture, toggles, fistula
devices, etc.) are only significant if they are
associated with active (i.e. the presence of fibrin as
opposed to chronic peritonitis with fibrous adhesions)
peritoneal inflammation.
- Injection sites – carcasses with lesions associated
with injections. Injection sites are likely to be found
in a variety of locations including the neck, shoulder,
thorax, axilla, ventral abdomen (along the subcutaneous
abdominal vein), flank, hindquarter, pelvic area (perirectal)
and tail. Also, look for cellulitis that is away from
pressure points (e.g., tubor isschii, hip joint, stifle
joint). These are generally found in the semimembranosis
and semitendinosis muscle.
- Pneumonia – carcasses with acute, subacute
and chronic active pneumonias; with pleural cellulitis resulting from
reticulo peritonitis complex; or with embolic pneumonia.
- Pericarditis – carcasses with fibinous or
fibrinosuppurative pericarditis.
- Endocarditis – carcasses with endocarditis and acute
pulmonary, renal or other embolic lesions. Also, test
carcasses that are condemned due to septicemia, pyemia,
or other reasons.
- Abomasal disease – carcasses with recent abomasal
displacement and abomasal torsions or with
intussusceptions, mesenteric torsions, and cecal
torsions.
- Septicemia and pyemia – carcasses that are being
condemned for septicemia, pyemia, or other
inflammatory/infectious conditions.
- Downers - carcasses of any animal that was
non-ambulatory.
- Animals identified during ante-mortem inspection
that were determined to be U.S. Suspect for residues.
- Carcasses with acute cellulitis or other acute
inflammations associated with a fibinous or
fibrinosuppurative exudate in any location on the
carcass or viscera.
Philip S. Derfler /s/
Assistant Administrator
Office of Policy, Program, and Employee Development
| DISTRIBUTION:
Inspection Offices; T/A Inspectors; Plant
Mgt; TRA; ABB; TSC; Import Offices |
NOTICE
EXPIRES: 11-01-02 |
OPI:
OPPED |
|
